Company Overview

PRIME exits and American HealthCare Capital are pleased to exclusively introduce an Orthotics & Prosthetics (O&P) company for sale in the Mid-Atlantic area. The company has been in business since 2001 and has four locations in this region and a fabrication lab. It provides comprehensive, custom O&P care for patients with custom orthoses, upper and lower extremity prostheses, and compression therapy, utilizing the most advanced technology for its products and services. 

Core Competencies

• Complete orthotic services for spine and limbs

• Complete adult custom orthotic and prosthetic services for upper and lower extremities

• Complete pediatric custom orthotic and prosthetic services for upper and lower extremities

• Complete compression and lymphedema products and services

• Quality-assured products

• Certified professionals

• On-site fabrication laboratory

Differentiators

• 4 ABC Certified Facilities

• 3 CPOs (Certified Prosthetist Orthotist)

• 3 Orthotic Specialists

• 2 Fabrication Lab Technicians

Product Mix

The Company’s product mix is 53% Prosthetics, 32% Durable Medical Equipment (DME), 13% Orthotics, and 2% Other.

Financial Overview

Company revenue was approximately $4.9 million in 2022. The Company’s compression device product line was discontinued due to the insurance industry changing fee reimbursement, reducing revenue in 2023 and 2024 to roughly $2.8 million. The adjusted EBITDA in 2024 was $215,000 or 8% adjusted EBITDA margin. In 2025, the Company’s plan has growth drivers and cost efficiencies. Gross revenue is projected to grow to $3.7 million in 2025 with an adjusted EBITDA of $537,000 (14%).

Asking Price

The asking price for this multi-location orthotics and prosthetics company is $2.5 million, and the sellers would consider an earn-out. This does not include cash, receivables, working capital, or real estate.